(Q68177118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

title

Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference

https://api.crossref.org/works/10.1023/A:1015815624334

15 October 2022

pharmaceutical science

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1023/A:1015815624334

15 October 2022

1 reference

https://api.crossref.org/works/10.1023/A:1015815624334

15 October 2022

1 reference

https://api.crossref.org/works/10.1023/A:1015815624334

15 October 2022

1 reference

https://api.crossref.org/works/10.1023/A:1015815624334

15 October 2022

author name string

T. P. Johnston

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1614979

15 October 2022

M. A. Punjabi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1614979

15 October 2022

C. J. Froelich

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1614979

15 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1614979

15 October 2022

publication date

1 March 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

published in

Pharmaceutical Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

page(s)

425-434

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

Recovery of the in vivo cytotoxic T-cell response in cyclophosphamide-treated mice by injection of mixed-lymphocyte-culture supernatants

22 September 2019

cites work

1 reference

12 December 2020

Application of an interleukin 2 slow delivery system to the immunotherapy of established murine colon 26 adenocarcinoma liver metastases

1 reference

12 December 2020

T cell factor (interleukin 2) allows in vivo induction of T helper cells against heterologous erythrocytes in athymic (nu/nu) mice

1 reference

12 December 2020

Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

1 reference

12 December 2020

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

12 December 2020

The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

12 December 2020

Enhancement of therapeutic effects of recombinant interleukin 2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle, pluronic gel

1 reference

12 December 2020

Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2.

1 reference

12 December 2020

Sustained-release of urease from a poloxamer gel matrix

1 reference

12 December 2020

Inulin disposition following intramuscular administration of an inulin/poloxamer gel matrix.

1 reference

12 December 2020

Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat

1 reference

12 December 2020

1 reference

12 December 2020

Interleukin 2 (IL 2) administered in vivo: influence of IL 2 route and timing on T cell growth

1 reference

12 December 2020

Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues.

1 reference

12 December 2020

In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells

1 reference

12 December 2020

The fate of interleukin-2 after in vivo administration

1 reference

12 December 2020

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2

1 reference

12 December 2020

Slow release of interleukin-2 from polymer implants

1 reference

12 December 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1614979%20AND%20SRC:MED&resulttype=core&format=json

22 September 2019

1 reference